Damas, K.
1098  Ergebnisse:
Personensuche X
?
 
?
5

Prior statin use and 90-day mortality in Gram-negative and ..:

Mehl, A. ; Harthug, S. ; Lydersen, S....
European Journal of Clinical Microbiology & Infectious Diseases.  34 (2014)  3 - p. 609-617 , 2014
 
?
7

Expression of Toll-like receptor-3 is enhanced in active in..:

Østvik, A E ; Granlund, A v B ; Torp, S H...
Clinical and Experimental Immunology.  173 (2013)  3 - p. 502-511 , 2013
 
?
9

Enhanced levels of CCL19 in patients with advanced acquired..:

Damås, J K ; Øktedalen, O ; Ueland, T...
Clinical and Experimental Immunology.  167 (2012)  3 - p. 492-498 , 2012
 
?
11

Chemokines and common variable immunodeficiency; possible c..:

Fevang, B ; Yndestad, A ; Damås, J K...
Clinical and Experimental Immunology.  158 (2009)  2 - p. 237-245 , 2009
 
?
12

CXCL16 in HIV infection – a link between inflammation and v..:

Landrø, L. ; Damås, J. K. ; Halvorsen, B....
European Journal of Clinical Investigation.  39 (2009)  11 - p. 1017-1024 , 2009
 
?
13

C-reactive protein, infarct size, microvascular obstruction..:

Orn, S. ; Manhenke, C. ; Ueland, T....
European Heart Journal.  30 (2009)  10 - p. 1180-1186 , 2009
 
?
14

Homeostatic chemokines CCL19 and CCL21 promote inflammation..:

Damås, J K ; Landrø, L ; Fevang, B...
Clinical and Experimental Immunology.  157 (2009)  3 - p. 400-407 , 2009
 
?
15

Decreased serum lipocalin-2 levels in human immunodeficienc..:

Landrø, L ; Damås, J K ; Flo, T H...
Clinical and Experimental Immunology.  152 (2008)  1 - p. 57-63 , 2008
 
1-15